| Literature DB >> 35199675 |
Harish Chandra Neupane1, Tseten Yonjen Tamang1, Santosh Timalsina2, Kishor Kumar Tamrakar1, Abhishek Bhattarai1.
Abstract
INTRODUCTION: Pancreaticoduodenectomy (Whipple procedure), even after significant evolution, continues to be associated with a high morbidity. The study aimed to find out the prevalence of complications following pancreaticoduodenectomies performed by a single surgeon over a span of 20 years in tertiary care hospitals of Nepal.Entities:
Keywords: developing countries; pancreaticoduodenectomy; pancreatic fistula.
Mesh:
Year: 2022 PMID: 35199675 PMCID: PMC9157660 DOI: 10.31729/jnma.7050
Source DB: PubMed Journal: JNMA J Nepal Med Assoc ISSN: 0028-2715 Impact factor: 0.556
Complications observed in the patients undergoing pancreatoduodenectomy (n = 327).
| Variables | Overall n (%) | 1st decade (n= 162) n (%) | 2nd decade (n= 165) n (%) |
|---|---|---|---|
| Specific complications | |||
| DGE | 13 (4.0) | 11 (6.8) | 2 (1.2) |
| Intra-abdominal abscess | 5 (1.5) | 2(1.2) | 3 (1.8) |
| Gastrointestinal | 14 (4.3) | 5 (3.1) | 9 (5.5) |
| Respiratory | 32 (9.8) | 14 (9.6) | 18 (10.9) |
| Cardiac | 24 (7.3) | 12 (7.4) | 12 (7.3) |
| Renal | 14 (4.3) | 6 (3.7) | 8 (4.8) |
| Neurological | 5 (1.5) | 2 (1.2) | 3 (1.8) |
| PPH | 5 (1.5) | 4(2.5) | 1 (0.6) |
| POPF | 5 (1.5) | 4(2.5) | 1 (0.6) |
| Bile leak | - | - | - |
| SSI | 10 (3.1) | 5 (3.1) | 5 (3.0) |
| Septicemia | 25 (7.6) | 14 (10.2) | 11 (7.3) |
| Others | 22 (6.7) | 11 (6.8) | 11 (6.7) |
| Readmission | 5 (1.5) | 2 (1.2) | 3 (1.8) |
| Re-operation | 1 (0.3) | 1 (0.6) | 0 (0.0) |
| Mortality | 10 (3.1) | 8 (4.9) | 2 (1.2) |
| Total | 125 (38.2) | 66 (40.7) | 59 (35.8) |
DGE= Delayed Gastric Emptying
PPH= Postpancreatectomy hemorrhage
POPF= Postoperative pancreatic fistula
SSI= Surgical site infection
Sociodemographic characteristics and operative parameters of patients.
| Variables | Overall (n= 327) n (%) | 1st decade (n= 162) n (%) | 2nd decade (n= 165) n (%) |
|---|---|---|---|
| Socio-demographic data | |||
| Sex | |||
| Male | 140 (42.8) | 71 (43.8) | 69 (41.8) |
| Female | 187 (57.2) | 91 (56.2) | 96 (58.2) |
| Symptoms | |||
| Jaundice | 163 (49.8) | 76 (46.9) | 87 (52.7) |
| Loss of weight | 37 (11.3) | 24 (14.8) | 13 (7.9) |
| Abdominal pain | 66 (20.2) | 33 (20.4) | 33 (20.0) |
| Nausea and vomiting | 37 (11.3) | 18 (11.1) | 19 (11.5) |
| Others | 24 (7.3) | 11 (6.8) | 13 (7.9) |
| Pre-existing co-morbidity | |||
| HTN | 90 (27.5) | 47 (29.0) | 43 (26.1) |
| IHD | 22 (6.7) | 13 (8.0) | 9 (5.5) |
| Dysrhythmia | 12 (3.7) | 7 (4.3) | 5 (3.0) |
| CVA | 9 (2.8) | 3(1.9) | 6 (3.6) |
| PVD | 3 (0.9) | 2 (1.2) | 1 (0.6) |
| COPDf | 27 (8.3) | 10 (6.2) | 17 (10.3) |
| Diabetes mellitus | 32 (9.8) | 14 (8.6) | 18 (10.9) |
| Renal disorders | 3 (0.9) | 2 (1.2) | 1 (0.6) |
| Others | 55 (16.8) | 30 (18.5) | 25 (15.2) |
| Blood transfusion | |||
| Needed | 129 (39.4) | 68 (42.0) | 61 (37.0) |
|
|
|
|
|
| 300 (0-5500) | 350 (0-5000) | 300 (0-5500) | |
|
|
|
|
|
|
|
|
| |
| Operative time (min) | 261.2±55.1 | 263.8±51.4 | 258.6±58.5 |
| Length of post-operative hospital stay (days), mean±SD | 15.6±4.7 | 15.8±4.7 | 15.4±4.6 |
HTN= Hypertension
IHD= Ischemic Heart Disease
CVA= Cerebrovascular Accident
PVD= Peripheral Vascular Disease
COPD= Chronic Obstructive Pulmonary Disease
DM= Diabetes Mellitus
FFP=Fresh Frozen Plasma
Histopathological diagnosis of the patients.
| Pathological diagnosis | Overall (n = 327) n (%) | 1st decade (n= 162) n (%) | 2nd decade (n= 165) n (%) |
|---|---|---|---|
| Benign | 53 (16.2) | 23 (14.2) | 30 (18.2) |
| Adenoma | 37 (11.3) | 20 (12.3) | 17 (10.3) |
| Duodenal polyp | 2 (0.6) | 0 (0.0) | 2 (1.2) |
| Ganglionic tumor | 1 (0.3) | 0 (0.0) | 1 (0.6) |
| Neuroendocrine tumor | 1 (0.3) | 1 (0.7) | 0(0.0) |
| Pancreatitis | 11 (3.4) | 2 (1.2) | 9(5.5) |
| Unspecified | 1 (0.3) | 0(0.0) | 1 (0.6) |
| Malignant | 274 (83.8) | 139 (85.8) | 135 (81.8) |
| Periampullary carcinoma | 232 (70.9) | 122 (75.3) | 110 (66.7) |
| Cholangi ocarcinoma | 13 (4.0) | 7 (4.3) | 6 (3.6) |
| Cystic mucinous adenocarcinoma | 4(1.2) | 3(1.9) | 1 (0.6) |
| Intestinal adenocarcinoma | 10 (3.0) | 0 (0.0) | 10 (6.1) |
| Lymphoma | 11 (3.4) | 6 (3.7) | 5 (3.0) |
| Neuroendocrine tumor | 4(1.2) | 1 (0.6) | 3 (1.8) |